Search results
Axogen Inc. [AXGN] Records 50-Day SMA of $6.88 – Knox Daily
Knox Daily· 1 day agoAnalysts at Canaccord Genuity upgraded the stock from ‘”a Hold”‘ to ‘”a Buy”‘ outlook in a report released in early May. Earlier on October 23, 2020, Guggenheim initiated ...
Endava (NYSE:DAVA) Receives New Coverage from Analysts at Redburn Atlantic
ETF DAILY NEWS· 1 day agoEquities researchers at Redburn Atlantic began coverage on shares of Endava (NYSE:DAVA – Get Free Report) in a note issued to investors on Friday, Briefing.com reports. The brokerage set a “ ...
A company insider recently sold 5,000 shares of Enphase Energy Inc [ENPH]. Should You also Consider...
Knox Daily· 4 days agoJefferies also remained covering ENPH and has decreased its forecast on April 24, 2024 with a “Hold” recommendation from previously “Buy” rating. Guggenheim revised its rating ...
Pfizer Inc.’s latest rating changes from various analysts – Knox Daily
Knox Daily· 5 days agoArgus downgraded its Pfizer Inc. [PFE] rating to a Hold from a a Buy in a research note published recently. A number of analysts have revised their coverage, including Guggenheim< ...
Mizuho Lowers Globant (NYSE:GLOB) Price Target to $252.00
ETF DAILY NEWS· 2 days agoThe firm presently has a “buy” rating on the information technology services provider’s stock. Mizuho’s price target suggests a potential upside of 46.74% from the stock’s current price. < ...
Joe Zucker, prolific painter of innumerable styles, dies at 82 - The Boston Globe
The Boston Globe· 23 hours ago“What I was and still am doing,” he told The Brooklyn Rail in 2010, “has always been about trying to...
BASE (Couchbase Inc) may reap gains as insiders became active recently – Knox Daily
Knox Daily· 5 days agoPercent R suggests that price movement has been bullish at 0.76%. Stochastics %K at 94.08% indicates the stock is a selling. The most recent change occurred on January 27, 2023 when
Taking a Closer Look At Roivant Sciences Ltd
Knox Daily· 5 days agoDeutsche Bank began covering ROIV with “Buy” recommendation on December 12, 2023. Guggenheim started covering the stock on October 17, 2023. It rated ROIV as “a Buy”. Price ...
RAPT Therapeutics, Inc. (NASDAQ:RAPT) Given Consensus Recommendation of “Hold” by Analysts
ETF DAILY NEWS· 2 days agoRAPT Therapeutics, Inc. (NASDAQ:RAPT – Get Free Report) has been assigned a consensus rating of “Hold” from the thirteen ratings firms that are covering the stock, Marketbeat.com reports. Nine ...
Investing in Akamai Technologies Inc [AKAM]: What You Must Know – Knox Daily
Knox Daily· 4 days agoSusquehanna began covering AKAM with “Positive” recommendation on December 15, 2023. Guggenheim revised its rating on October 26, 2023. It rated AKAM as “a Neutral” which ...
